| Literature DB >> 26484355 |
Alena Sekerkova1, Martin Fuchs2, Eva Cecrdlova1, Veronika Svachova1, Ivana Kralova Lesna3, Ilja Striz1, Helena Tlaskalova-Hogenova4.
Abstract
Background. Food protein-induced proctitis/proctocolitis (FPIP) is the most common noninfectious colitis in children in the first year of life. Along with the overall clinical symptoms, diarrhoea and rectal bleeding are the main manifestations of the disease. There is no routine noninvasive test that would be specific for this type of colitis. The aim of our study was to find a noninvasive laboratory test or tests that may be helpful in differential diagnosis of food protein-induced proctitis/proctocolitis. Methods. ANA, ANCA, ASCA, a-EMA, a-tTg, specific IgE, total IgE, IgG, IgA, IgM, and concentration of serum calprotectin were measured in a group of 25 patients with colitis and 18 children with other diagnoses. Results. Atypical-pANCA antibodies of IgG isotype were detected in the sera of 24 patients by the method of indirect immunofluorescence, and 5 patients showed also the positivity of IgA isotype. In control samples these autoantibodies were not detected. Other autoantibodies were not demonstrated in either patient or control group. Conclusions. Of the parameters tested in noninfectious colitis, atypical-pANCA on ethanol-fixed granulocytes appears to be a suitable serological marker of food protein-induced proctitis/proctocolitis and suggests a possible involvement of an autoimmune mechanisms in the pathogenesis of this disease.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26484355 PMCID: PMC4592904 DOI: 10.1155/2015/902863
Source DB: PubMed Journal: J Immunol Res ISSN: 2314-7156 Impact factor: 4.818
Major features of the 25 infants with Food protein-induced proctitis/proctocolitis.
| Patient (sex) | Age month | Diet | dg. parents | a-pANCA IgG | a-pANCA IgA | ANA IgG | ANCA profile | ASCA | a-EMA | a-EMA | a-tTg | a-tTg | Prick tests | Phadiatop | FX5 | Calprotectin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 (M) | 6 | Milk hydrolyzate | — |
| Neg. | Neg. | Neg. | Neg. | — | — | 1 | 1 | Negative | — | <0.35 | — |
| 2 (F) | 2 | Breastfeeding | Mother IA |
|
| Neg. | Neg. | Neg. | Neg. | Neg. | 0.5 | 1 | Negative | — | <0.35 | 390 |
| 3 (F) | 5 | Milk hydrolyzate | Mother IA |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | <0.35 | <0.35 | 339 |
| 4 (M) | 2 | Breastfeeding | Mother IA |
| Neg. | Neg. |
| Neg. | — | — | — | — | Negative | <0.35 | <0.35 | 511 |
| 5 (F) | 7 | Milk hydrolyzate | — |
| Neg. |
| Neg. | Neg. | — | — | — | — | Negative | — | — |
|
| 6 (F) | 24 | Egg-free diet | Mother IA |
| Neg. | Neg. | Neg. | Neg. | Neg. | Neg. | 1.2 | 1 | Negative | 2.22 | <0.35 |
|
| 7 (F) | 1 | Breastfeeding | — |
| Neg. | Neg. |
| Neg. | Neg. | Neg. | 0.5 | 0.9 | Negative | <0.35 | <0.35 | 677 |
| 8 (M) | 1 | Breastfeeding | Father IA |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | <0.35 | 385 | |
| 9 (M) | 24 | — | Mother IA |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | <0.35 | <0.35 | — |
| 10 (M) | 2 | Breastfeeding | — |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | — | — | — |
| 11 (M) | 3 | Breastfeeding | Mother, father IA |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | — | <0.35 | 83 |
| 12 (F) | 24 | Mother IA, FA |
| Neg. | Neg. | Neg. | Neg. | Neg. | Neg. | 1.1 | 1 | Negative | <0.35 | <0.35 | 620 | |
| 13 (F) | 7 | Milk hydrolyzate | Mother IA, FA |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | <0.35 | <0.35 | 376 |
| 14 (M) | 23 | — | — |
|
| Neg. |
| Neg. | Neg. | Neg. | 2.69 | 1.1 | Negative | — | <0.35 | 641 |
| 15 (F) | 24 | — | Mother IA |
|
| Neg. |
| Neg. | Neg. | Neg. | 1 | 1.2 | Negative | <0.35 | <0.35 | 1014 |
| 16 (M) | 4 | Milk hydrolyzate | — |
| Neg. | Neg. | Neg. | Neg. | — | — | 1.1 | 1.1 | Negative | <0.35 | <0.35 | 510 |
| 17 (F) | 18 | Egg-free diet | Father IA |
| Neg. | Neg. | Neg. | Neg. | — | — | 1.1 | 1.2 | Negative | — | — | 548 |
| 18 (M) | 15 | — | Father IA | Neg. |
| Neg. | Neg. | Neg. | Neg. | Neg. | 1.1 | 1 | Negative | <0.35 | <0.35 | 1270 |
| 19 (F) | 18 | — | Mother celiakie |
| Neg. | Neg. | Neg. | Neg. | Neg. | Neg. | 1 | 1 | Negative | <0.35 | <0.35 | 1784 |
| 20 (F) | 6 | Milk hydrolyzate | — |
|
| Neg. | Neg. | Neg. | Neg. | Neg. | 1 | 1.1 | Negative | — | — | 821 |
| 21 (F) | 4 | Milk hydrolyzate | Father IA |
| Neg. | Neg. | Neg. | Neg. | Neg. | Neg. | 0.5 | 1.9 | Negative | <0.35 |
| 340 |
| 22 (M) | 6 | Milk hydrolyzate | Father ulcerative colitis |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | — |
| 443 |
| 23 (M) | 15 | Egg-free diet | — |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | — | — | 952 |
| 24 (F) | 1 | Breastfeeding | — |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | <0.35 | — | 454 |
| 25 (M) | 1 | Breastfeeding | Father IA |
| Neg. | Neg. | Neg. | Neg. | — | — | — | — | Negative | <0.35 | <0.35 | 980 |
IA: inhalation allergy.
FA: food allergy.
Figure 1Atypical p-ANCA (serum of patient with diagnosis of food protein-induced proctitis/proctocolitis).
| Diagnosis, patient group | Diagnosis, control group | ||
|---|---|---|---|
| Food protein-induced proctitis/proctocolitis | 25 | Asthma | 4 |
| Atopic eczema | 8 | Allergic rhinitis | 12 |
| Others | 1 | Others | 2 |
Others: vomiting, others: fever.
| Diet, patient group | Diet, control group | ||
|---|---|---|---|
| Breastfed | 8 | Without dietary restriction | 18 |
| Milk hydrolyzate | 5 | ||
| Amino acids | 3 | ||
| Egg-free diet | 3 | ||
| Without dietary restriction | 6 |
(a) Patient group
| IIF IgG | IIF IgA | |
|---|---|---|
| Negative | 1 | 20 |
| Positive | 24 | 5 |
(b) Control group
| IIF IgG | IIF IgA | |
|---|---|---|
| Negative | 18 | 18 |
| Positive | 0 | 0 |
| Patient group | Method | Negative | Weekly positive | Positive | Strongly positive |
|---|---|---|---|---|---|
| a-pANCA IgG | IIF | 1 | 3 | 14 | 7 |
| a-pANCA IgA | IIF | 20 | 0 | 3 | 2 |
| ANCA profile IgG | ELISA | 21 | 2 (2x PR3) | 2 (2x ELA) | 0 |
| ANA IgG | IIF | 24 | 0 | 1 (granular) | 0 |
| ASCA IgA | IIF | 25 | 0 | 0 | 0 |
| a-ENDO IgA | IIF | 10 | 0 | 0 | 0 |
| a-ENDO IgG | IIF | 10 | 0 | 0 | 0 |
| a-tTg IgA | ELISA | 13 | 0 | 0 | 0 |
| a-tTg IgG | ELISA | 13 | 0 | 0 | 0 |
| Control group | Method | Negative | Weekly positive | Positive | Strongly positive |
|---|---|---|---|---|---|
| a-pANCA IgG | IIF | 18 | 0 | 0 | 0 |
| a-pANCA IgA | IIF | 18 | 0 | 0 | 0 |
| ANCA profile IgG | ELISA | 18 | 0 | 0 | 0 |
| ANA IgG | IIF | 18 | 0 | 0 | 0 |
| ASCA IgA | IIF | 18 | 0 | 0 | 0 |
| a-ENDO IgA | IIF | 18 | 0 | 0 | 0 |
| a-ENDO IgG | IIF | 18 | 0 | 0 | 0 |
| a-tTg IgA | ELISA | 18 | 0 | 0 | 0 |
| a-tTg IgG | ELISA | 18 | 0 | 0 | 0 |
| Patient group | Method | Normal | Reduced | Increased |
|---|---|---|---|---|
| Total IgA | Nephelometry | 7 | 13 | 4 |
| Total IgG | Nephelometry | 16 | 5 | 2 |
| Total IgM | Nephelometry | 14 | 6 | 3 |
| Total IgE | Nephelometry | 13 | 0 | 8 |
| spec.IgE Phadiatop | FEIA | 16 | — | 0 |
| spec.IgE FX5 | FEIA | 18 | — | 2 |
| Calprotectin | ELISA | 21 | 0 | 2 |
| Control group | Method | Normal | Reduced | Increased |
|---|---|---|---|---|
| Total IgA | Nephelometry | 6 | 10 | 2 |
| Total IgG | Nephelometry | 12 | 6 | 0 |
| Total IgM | Nephelometry | 10 | 6 | 2 |
| Total IgE | Nephelometry | 8 | — | 10 |
| spec.IgE Phadiatop | FEIA | 8 | — | 6 |
| spec.IgE FX5 | FEIA | 12 | — | 4 |